Friedreich N: Uber degenerative Atrophie der spinalen Hinterstrange. Arch Pathol Anat Phys Klin Med. 1863, 26: 391-419.
Article
Google Scholar
Harding AE: Classification of the hereditary ataxias and paraplegias. Lancet. 1983, 1: 1151-1155.
Article
CAS
PubMed
Google Scholar
Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Cañizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocazza S, Koenig M, Pandolfo M: Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996, 271: 1423-1427. 10.1126/science.271.5254.1423.
Article
CAS
PubMed
Google Scholar
Santos R, Lefevre S, Sliwa D, Seguin A, Camadro JM, Lesuisse E: Friedreich ataxia: molecular mechanisms, redox considerations and therapeutic opportunities. Antioxid Redox Signal. 2010, 13: 651-690. 10.1089/ars.2009.3015.
Article
CAS
PubMed
PubMed Central
Google Scholar
Axelson M, Kirk DN, Farrant RD, Cooley G, Lawson AM, Setchell KD: The identification of the weak oestrogen equol [7-hydroxy-3-(4’-hydroxyphenyl)chroman] in human urine. Biochem J. 1982, 201: 353-357.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang XL, Hur HG, Lee JH, Kim KT, Kim SI: Enantioselective synthesis of S-equol from dihyrodaidzein by a newly isolated anaerobic human intestinal bacterium. Appl Environ Microbiol. 2005, 71: 214-219. 10.1128/AEM.71.1.214-219.2005.
Article
CAS
PubMed
PubMed Central
Google Scholar
Price KR, Fenwick GR: Naturally occurring oestrogens in foods – a review. Food Addit Contam. 1985, 2: 73-106. 10.1080/02652038509373531.
Article
CAS
PubMed
Google Scholar
Kelly GE, Nelson C, Waring MA, Joannou GE, Reeder AY: Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta. 1993, 223: 9-22. 10.1016/0009-8981(93)90058-C.
Article
CAS
PubMed
Google Scholar
Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim WJ, Song JM, Pantuck AJ: Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol. 2004, 34: 86-89. 10.1093/jjco/hyh015.
Article
PubMed
Google Scholar
Pereboom D, Gilaberte Y, Sinues B, Escanero J, Alda JO: Antioxidant intracellular activity of genistein and equol. J Med Food. 1999, 2: 253-256. 10.1089/jmf.1999.2.253.
Article
CAS
PubMed
Google Scholar
Mitchell JH, Gardner PT, McPhail DB, Morrice PC, Collins AR, Duthie GG: Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys. 1998, 360: 142-148. 10.1006/abbi.1998.0951.
Article
CAS
PubMed
Google Scholar
Duncan AM, Merz-Demlow BE, Xu X, Phipps WR, Kurzer MS: Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2000, 9: 581-586.
CAS
PubMed
Google Scholar
Lund TD, Munson DJ, Haldy ME, Setchell KD, Lephart ED, Handa RJ: Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod. 2004, 70: 1188-1195.
Article
CAS
PubMed
Google Scholar
Mitchell JH, Duthie SJ, Collins AR: Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP. Nutr Cancer. 2000, 38: 223-228. 10.1207/S15327914NC382_12.
Article
CAS
PubMed
Google Scholar
Frankenfeld CL, McTiernan A, Aiello EJ, Thomas WK, LaCroix K, Schramm J, Schwartz SM, Holt VL, Lampe JW: Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2004, 13: 1156-1162.
CAS
PubMed
Google Scholar
Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA: Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem. 2004, 12: 1559-1567. 10.1016/j.bmc.2003.11.035.
Article
CAS
PubMed
Google Scholar
Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ, Heubi JE: S-Equol, a potent ligand for estrogen receptor {beta}, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr. 2005, 81: 1072-1079.
CAS
PubMed
Google Scholar
Richardson TE, Yang SH, Wen Y, Simpkins JW: Estrogen protection in Friedreich’s ataxia skin fibroblasts. Endocrinology. 2011, 152: 2742-2749. 10.1210/en.2011-0184.
Article
CAS
PubMed
PubMed Central
Google Scholar
Richardson TE, Yu AE, Wen Y, Yang SH, Simpkins JW: Estrogen prevents oxidative damage to the mitochondria in Friedreich’s ataxia skin fibroblasts. PLoS One. 2012, 7: e13600-
Google Scholar
Marmolino D: Friedreich’s ataxia: past, present and future. Brain Res Rev. 2011, 67: 311-330. 10.1016/j.brainresrev.2011.04.001.
Article
CAS
PubMed
Google Scholar
Klopstock T, Chahrokh-Zadeh S, Holinski-Feder E, Meindl A, Gasser T, Pongratz D, Müller-Felber W: Markedly different course of Friedreich’s ataxia in sib pairs with similar GAA repeat expansions in the frataxin gene. Acta Neuropathol. 1999, 97: 139-142. 10.1007/s004010050966.
Article
CAS
PubMed
Google Scholar
Leone M, Brignolio F, Rosso MG, Curtoni ES, Moroni A, Tribolo A, Schiffer D: Friedreich’s ataxia: a descriptive epidemiological study in an Italian population. Clin Genet. 1990, 38: 161-169.
Article
CAS
PubMed
Google Scholar
Simpkins JW, Green PS, Gridley KE, Singh M, de Fiebre NC G, Rajakumar G: Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am J Medicine. 1997, 103: 195-255.
Article
Google Scholar
Behl C: Oestrogen as a neuroprotective hormone. Nat Rev Neurosci. 2002, 3: 433-442.
CAS
PubMed
Google Scholar
Jauslin ML, Wirth T, Meier T, Shoumacher F: A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy. Hum Mol Genet. 2002, 11: 3055-63. 10.1093/hmg/11.24.3055.
Article
CAS
PubMed
Google Scholar
Jauslin ML, Meier T, Smith RA, Murphy MP: Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J. 2003, 17: 1972-4.
CAS
PubMed
Google Scholar
Prokai L, Prokai-Tatrai K, Perjesi P, Simpkins JW: Mechanistic insights into the direct antioxidant effects of estrogens. Drug Dev Res. 2006, 66: 118-125.
Article
Google Scholar
Prokai L, Prokai-Tatrai K, Perjesi P, Zharikova AD, Perez EJ, Liu R, Simpkins JW: Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci USA. 2003, 100: 11741-11746. 10.1073/pnas.2032621100.
Article
CAS
PubMed
PubMed Central
Google Scholar
Montano MM, Bianco NR, Deng H, Wittmann BM, Chaplin LC, Katzenellenbogen BS: Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen. Front Biosci. 2005, 10: 1440-1461. 10.2741/1630.
Article
CAS
PubMed
Google Scholar
Viña J, Sastre J, Pallardó FV, Gambini J, Borrás C: Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens. Free Radic Res. 2006, 40: 1359-1365. 10.1080/10715760600952851.
Article
PubMed
Google Scholar
Pajović SB, Saicić ZS: Modulation of antioxidant enzyme activities by sexual steroid hormones. Physiol Res. 2008, 57: 801-811.
PubMed
Google Scholar
Simpkins JW, Dykens JA: Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev. 2008, 57: 421-430. 10.1016/j.brainresrev.2007.04.007.
Article
CAS
PubMed
Google Scholar
Duckles SP, Miller VM: Hormonal modulation of endothelial NO production. Pflugers Arch. 2010, 459: 841-851. 10.1007/s00424-010-0797-1.
Article
CAS
PubMed
PubMed Central
Google Scholar
White RE, Gerrity R, Barman SA, Han G: Estrogen and oxidative stress: a novel mechanism that may increase the risk for cardiovascular disease in women. Steroids. 2010, 75: 788-793. 10.1016/j.steroids.2009.12.007.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liang Y, Belford S, Tang F, Prokai L, Simpkins JW, Hughes JA: Membrane fluidity effects of estratrienes. Brain Res Bull. 2001, 54: 661-668. 10.1016/S0361-9230(01)00483-X.
Article
CAS
PubMed
Google Scholar
Cegelski L, Rice CV, O'Connor RD, Caruano AL, Tochtrop GP, Cai ZY, Covey DF, Schaefer J: Mapping the locations of estradiol and potent neuroprotective analogues in phospholipid bilayers by REDOR NMR. Drug Dev Res. 2006, 66: 93-102.
Article
Google Scholar